Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. CytoDyn Inc (CYDY) Message Board

I’m limiting my posting because some feel I have

Message Board Public Reply | Private Reply | Keep | Replies (4)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 154646
(Total Views: 399)
Posted On: 06/28/2025 12:41:48 PM
Posted By: Evil Rabbit
I’m limiting my posting because some feel I have too much influence with my opinions and I simply don’t want that responsibility.

That said, I feel compelled to point out that little has changed between when we were at .40 and now at .25

Leronlimab is still incredible.

In fact, we’ve only had good news recently with the old CRC data and the Barcelona poster, and word of the new CRC trial finally getting underway.

However, if one just based their assessment of the drug and the company on the general sentiment on this board, you’d think the data showed LL in a poor light or the company is in trouble.

So what are shareholders currently freaking out about?

Let’s start with the CRC trial using 350mg. That’s only the first 5 patients, just to appease the (slow-to-grasp-the-MOA) FDA and those patients will likely have their dose upped as the trial continues. Don’t worry, that trial is sure to deliver amazing data.

Next, the lawsuit. We’ve seen these before. They are exploited by shorts and are mostly ambulance chasing bunk. Ignore it. Even if the company ends up settling, it’s peanuts.

Now, the only fair criticism I think right now is lack of communication from mgmt and IR ignoring emails. However, I have to assume because we did NOT get the expected Shareholder Letter from Jay which would typically have arrived in June, we are in talks and something good is afoot.

Admittedly, it sucks seeing the sp drop so hard and fast. We all have PTSD from the $10 drop. I believe we’re on the cusp of a partnership announcement. Hopefully sooner than later.

So try (not easy) to ignore the sp fluctuations, add if you’re able/comfortable, and don’t stop believin’…

Okay, back to my own silence.


(31)
(0)




CytoDyn Inc (CYDY) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us